{"id":3077,"date":"2013-10-31T16:18:54","date_gmt":"2013-10-31T14:18:54","guid":{"rendered":"http:\/\/www.ced.org.tr\/?p=3077"},"modified":"2013-10-31T16:18:54","modified_gmt":"2013-10-31T14:18:54","slug":"glaxosmithkline-rusvet-suclamasini-kabul-etti","status":"publish","type":"post","link":"http:\/\/www.ced.org.tr\/?p=3077","title":{"rendered":"GlaxoSmithKline r\u00fc\u015fvet su\u00e7lamas\u0131n\u0131 kabul etti"},"content":{"rendered":"<div style=\"color: #222222; font-family: arial, sans-serif; font-size: 12.800000190734863px;\">\n<p>BBC<\/p>\n<p>\u015eirket yetkilileri, ila\u00e7 sat\u0131\u015flar\u0131n\u0131 artt\u0131rmak i\u00e7in bir &#8216;r\u00fc\u015fvet sistemi&#8217; i\u015fletmekle su\u00e7lan\u0131yor.<\/p>\n<p>\u00c7in h\u00fck\u00fcmeti, GlaxoSmithKline yetkililerinin, seyahat acentalar\u0131n\u0131 ve doktorlar\u0131 kullanarak milyonlarca dolar r\u00fc\u015fvet verdiklerini iddia ediyor.<\/p>\n<p>\u015eirketin baz\u0131 yetkilileri de, hayal\u00ee konferanslar d\u00fczenleyerek, seyahat acentalar\u0131 arac\u0131l\u0131\u011f\u0131yla doktorlara ve sa\u011fl\u0131k yetkililerine r\u00fc\u015fvet verdiklerini kabul ettiler.<\/p>\n<p>\u00c7in h\u00fck\u00fcmetinin, \u0130ngiltere&#8217;nin en b\u00fcy\u00fck ila\u00e7 \u00fcreticisi GlaxoSmithKline hakk\u0131nda r\u00fc\u015fvet ve vergi usuls\u00fczl\u00fckleri nedeniyle ba\u015flatt\u0131\u011f\u0131 soru\u015fturma ard\u0131ndan \u015firket yetkilileri, baz\u0131 \u00fcst d\u00fczey yetkililerin \u00c7in yasalar\u0131n\u0131 \u00e7i\u011fnemi\u015f olabilece\u011fini a\u00e7\u0131klad\u0131.<\/p>\n<\/div>\n<div style=\"color: #222222; font-family: arial, sans-serif; font-size: 12.800000190734863px;\">\n<p>Soru\u015fturman\u0131n ba\u015flamas\u0131 ard\u0131ndan \u00c7in&#8217;e giden GlaxoSmithKline&#8217;\u0131n y\u00f6neticilerinden Abbas H\u00fcseyin, yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, &#8220;\u015eirketimiz bu t\u00fcr davran\u0131\u015flara kar\u015f\u0131 s\u0131f\u0131r-tolerans politikas\u0131 y\u00fcr\u00fctmektedir&#8221; dedi.<\/p>\n<div>Dev ila\u00e7 \u015firketinin \u00c7in&#8217;deki muhasebe birimi ba\u015fkan\u0131, g\u00fcvenlik g\u00fc\u00e7leri taraf\u0131ndan g\u00f6zalt\u0131na al\u0131nm\u0131\u015ft\u0131.<\/div>\n<p>\u015eirketin bir ba\u015fka y\u00f6neticisi Steve Nechelput&#8217;a da \u00fclkeden \u00e7\u0131k\u0131\u015f yasa\u011f\u0131 getirildi\u011fi belirtiliyor.<\/p>\n<p>Abbas H\u00fcseyin, &#8220;GlaxoSmithKline&#8217;\u0131n \u00e7al\u0131\u015fma prensiplerini \u00e7ok iyi bilen \u00c7in&#8217;deki baz\u0131 y\u00f6neticilerinin bu prensiplerin d\u0131\u015f\u0131nda uygulamalar yapt\u0131klar\u0131, bunlar\u0131n da \u00c7in yasalar\u0131n\u0131 ihl\u00e2l etmi\u015f olabilece\u011fi anla\u015f\u0131l\u0131yor&#8221; dedi.<\/p>\n<p>\u00c7inli yetkililerin yolsuzlu\u011fu sona erdirmek konusundaki kararl\u0131l\u0131\u011f\u0131 payla\u015ft\u0131klar\u0131n\u0131 belirten H\u00fcseyin, &#8220;Bu soru\u015fturman\u0131n gerektirdi\u011fi t\u00fcm i\u015fbirli\u011fini sa\u011flayarak bu sorunun k\u00f6k\u00fcne inmeye kararl\u0131y\u0131z&#8221; dedi.<\/p>\n<p>Abbas H\u00fcseyin, GlaxoSmithKline&#8217;\u0131n \u00c7in&#8217;deki sat\u0131\u015f fiyatlar\u0131n\u0131 d\u00fc\u015f\u00fcrece\u011fini de a\u00e7\u0131klad\u0131.<\/p>\n<p>\u015eirket yetkilileri, ila\u00e7 sat\u0131\u015flar\u0131n\u0131 artt\u0131rmak i\u00e7in bir &#8216;r\u00fc\u015fvet sistemi&#8217; i\u015fletmekle su\u00e7lan\u0131yor.<\/p>\n<p>\u00c7in h\u00fck\u00fcmeti, GlaxoSmithKline yetkililerinin, seyahat acentalar\u0131n\u0131 ve doktorlar\u0131 kullanarak milyonlarca dolar r\u00fc\u015fvet verdiklerini iddia ediyor.<\/p>\n<p>\u015eirketin baz\u0131 yetkilileri de, hayal\u00ee konferanslar d\u00fczenleyerek, seyahat acentalar\u0131 arac\u0131l\u0131\u011f\u0131yla doktorlara ve sa\u011fl\u0131k yetkililerine r\u00fc\u015fvet verdiklerini kabul ettiler.<\/p>\n<p>\u00c7in yetkililerinin a\u00e7\u0131klamas\u0131nda soru\u015fturmada &#8216;\u00e7ok say\u0131da ki\u015fi, \u00e7ok b\u00fcy\u00fck miktarda para ve pek \u00e7ok su\u00e7 eylemi&#8217; bulundu\u011fu belirtildi.<\/p>\n<p>\u00c7in&#8217;de g\u00f6rev yapan \u00fcst d\u00fczey GlaxoSmithKline yetkililerinin, resm\u00ee g\u00f6revlilere, sa\u011fl\u0131k \u00f6rg\u00fctlerine, hastanelere ve doktorlara r\u00fc\u015fvet verdikleri ifade ediliyor.<\/p>\n<p>E\u011fer \u00c7in&#8217;de y\u00fcr\u00fct\u00fclen soru\u015fturma sonucunda GlaxoSmithKline su\u00e7lu bulunursa, \u0130ngiltere ve Amerika Birle\u015fik Devletleri&#8217;nde de benzer davalarla kar\u015f\u0131 kar\u015f\u0131ya kalabilir.<\/p>\n<p><a href=\"http:\/\/www.bbc.co.uk\/turkce\/ekonomi\/2013\/07\/130722_glaxo_cin.shtml\" target=\"_blank\" style=\"color: #1155cc;\">http:\/\/www.bbc.co.uk\/turkce\/ekonomi\/2013\/07\/130722_glaxo_cin.shtml<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>BBC \u015eirket yetkilileri, ila\u00e7 sat\u0131\u015flar\u0131n\u0131 artt\u0131rmak i\u00e7in bir &#8216;r\u00fc\u015fvet sistemi&#8217; i\u015fletmekle su\u00e7lan\u0131yor. \u00c7in h\u00fck\u00fcmeti, GlaxoSmithKline yetkililerinin, seyahat acentalar\u0131n\u0131 ve doktorlar\u0131&#46;&#46;&#46;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[62],"tags":[],"class_list":["post-3077","post","type-post","status-publish","format-standard","hentry","category-sagliktan-haberler"],"aioseo_notices":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/3077","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3077"}],"version-history":[{"count":0,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/3077\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3077"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3077"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}